SHARE CAPITAL | 6. SHARE CAPITAL Authorized The Company’s authorized share capital consists of an unlimited number of common shares without par value. At December 31, 2021 and September 30 issued outstanding Share issuances During the nine months ended September 30 There were no share issuances during the nine months ended September 30 Stock options The Company adopted an incentive stock option plan in 2006, as amended September 19, 2012, and reapproved by the Company’s shareholders on May 28, 2015, May 30, 2018, and May 25, 2021 (the “Stock Option Plan”). The essential elements of the Stock Option Plan provide that the aggregate number of common shares of the Company that may be issued pursuant to options granted under the Stock Option Plan and any other share-based compensation arrangements may not exceed 10% of the number of issued shares of the Company at the time of the granting of options. Options granted under the Stock Option Plan will have a maximum term of ten years. The exercise price of options granted under the Stock Option Plan shall be fixed in compliance with the applicable provisions of the Toronto Stock Exchange (“TSX”) Company Manual in force at the time of grant and, in any event, shall not be less than the closing price of the Company’s common shares on the TSX on the trading day immediately preceding the day on which the option is granted, or such other price as may be agreed to by the Company and accepted by the TSX. Options granted under the Stock Option Plan vest immediately, unless otherwise determined by the Board at the date of grant. A summary of the options granted under the Stock Option Plan as of September 30, 2022 and December 31, 2021 is presented below: Nine Months Ended Year Ended September 30, 2022 December 31, 2021 Weighted Weighted Average Aggregate Average Aggregate Number of Exercise Price Intrinsic Value Number of Exercise Price Intrinsic Value Options (C$) (C$) Options (C$) (C$) Balance, beginning of the period 2,947,049 $ 0.97 2,707,049 $ 0.94 Granted 240,000 0.92 240,000 1.31 Exercised (405,000) 0.90 — — Cancelled (495,000) 1.08 — — Balance, end of the period 2,287,049 $ 0.95 $ 64,782 2,947,049 $ 0.97 $ 235,200 The weighted average remaining life of options outstanding at September 30 Stock options outstanding as at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 December 31, 2021 Exercise Number of Exercise Number of Expiry Date Price (C$) Options Exercisable Price (C$) Options Exercisable March 25, 2022* — — — $ 1.11 510,000 510,000 March 25, 2022* — — — $ 0.73 270,000 270,000 March 25, 2022* — — — $ 1.11 120,000 120,000 March 16, 2023 $ 1.00 580,000 580,000 $ 1.00 580,000 580,000 March 16, 2023 $ 0.50 130,000 130,000 $ 0.50 130,000 130,000 June 9, 2023 $ 1.00 30,000 30,000 $ 1.00 30,000 30,000 March 21, 2024 $ 0.61 374,817 374,817 $ 0.61 374,817 374,817 February 1, 2025 $ 1.35 250,000 250,000 $ 1.35 250,000 250,000 August 8, 2025 $ 0.85 187,232 187,232 $ 0.85 187,232 187,232 May 27, 2026 $ 0.92 255,000 255,000 $ 0.92 255,000 170,000 May 25, 2027 $ 1.31 240,000 160,000 $ 1.31 240,000 80,000 May 24, 2028 $ 0.92 240,000 80,000 — — — 2,287,049 2,047,049 2,947,049 2,702,049 * Expiry date automatically extended to March 25, 2022, the tenth business day following the end of a blackout period imposed on the holders of the stock options, pursuant to the terms of the Stock Option Plan. A summary of the non-vested options as of September 30, 2022 and changes during the nine months ended September 30, 2022 is as follows: Weighted average Number of grant-date fair value Non-vested options: options (C$) Outstanding at December 31, 2021 245,000 $ 0.91 Granted 240,000 0.60 Vested (245,000) 0.78 Outstanding at September 30, 2022 240,000 $ 0.73 At September 30 Deferred Share Unit Incentive Plan On April 4, 2017, the Company adopted a Deferred Share Unit Plan (the “DSU Plan”). The DSU Plan was approved by the Company’s shareholders on May 24, 2017 and reapproved by the Company’s shareholders on May 27, 2020 and May 25, 2021. The maximum aggregate number of common shares that may be issued under the DSU Plan and the Stock Option Plan is 10% of the number of issued and outstanding common shares (on a non-diluted basis). During the nine months ended September 30 DSUs outstanding as at September 30, 2022 and December 31, 2021 are as follows: Nine Months Ended Year Ended September 30, 2022 December 31, 2021 Weighted Average Weighted Number of Exercise Price Number of Average Exercise Units (C$) Units Price (C$) Balance, beginning of the period 2,151,276 $ 0.88 1,834,481 $ 0.81 Issued 451,085 $ 0.92 316,795 $ 1.31 Balance, end of the period 2,602,361 $ 0.89 2,151,276 $ 0.88 Share-based payments During the nine months ended September 30, 2022, there were 240,000 stock options granted under the Stock Option Plan and 451,085 DSUs granted for common shares of the Company under the DSU Plan. Share-based payment compensation for the nine months ended September 30, 2022 totaled $427,834 ($114,811 related to stock options and $313,023 related to DSUs). Of the total expense for the period ended September 30, 2022, $320,762 was included in consulting fees ($7,739 related to stock options and $313,023 related to DSUs), $7,138 was included in investor relations, and $99,934 was included in wages and benefits in the statement of operations and comprehensive loss. During the nine months ended September 30, 2021, there were 240,000 stock options granted under the Stock Option Plan and 316,795 DSUs granted for common shares of the Company under the DSU Plan. Share-based payment compensation for the nine months ended September 30, 2021 totaled $505,101 ($137,251 related to stock options and $367,850 related to DSUs). Of the total expense for the period ended September 30, 2021, $378,645 was included in consulting fees ($10,795 related to stock options and $367,850 related to DSUs), $8,430 was included in investor relations, and $118,026 was included in wages and benefits in the statement of operations and comprehensive loss. The following weighted average assumptions were used for the Black-Scholes valuation model for stock options granted during the period: YTD September 30, 2022 Expected life of options 6 years Risk-free interest rate 2.64% Annualized volatility 76.75% Dividend rate 0.00% Exercise price (C$) $ 0.92 |